Ph II Nintedanib vs. Ifosfamide in Soft Tissue Sarcoma
Clinical trial NCT02808247 · TERMINATED
Trial details
- NCT number
- NCT02808247
- Sponsor
- European Organisation for Research and Treatment of Cancer - EORTC
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-07-07
- Primary completion
- 2020-11-03
- Enrollment
- 80
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.